
Nine of 10 patients with so-called “bubble boy” immune disease who received gene therapy about a decade ago are still disease-free, researchers report. The gene therapy was developed at the University of California, Los Angeles (UCLA), to treat the rare and deadly immune system disorder formally known as adenosine deaminase–deficient severe combined immunodeficiency (ADA-SCID). It’s… read on > read on >